John Garvey, a Foley Private Equity & Venture Capital Partner, moderated this session with panelists Josh Hamermesh of Molecular Insight Pharmaceuticals, Inc. and Matt Karlyn of Foley. They addressed in-licensing technology, specifically how to identify potential profit opportunities; approaching potential business partners, pre-transaction due diligence; negotiating with the licensor; and integration of the in-licensed technology into the company business operations.
Informações relacionadas
December 10, 2025
Foley Viewpoints
NAIC Fall Meeting Update: Climate and Resiliency (EX) Task Force
The mission of the Climate and Resiliency (EX) Task Force is to serve as the coordinating NAIC body for discussion and engagement on…
December 9, 2025
Foley Viewpoints
NAIC Fall Meeting Update: Reinsurance (E) Task Force Discusses Implementation of Actuarial Guideline LV for Testing Adequacy of Reserves in Life Reinsurance
On December 9, 2025, the Reinsurance (E) Task Force, which reports to the Financial Condition (E) Committee, met to discuss, among other…
December 9, 2025
Foley Viewpoints
NAIC Fall Meeting Update: Third-Party Data and Models (H) Working Group Exposes Risk-Based Regulatory Framework for Third-Party Data and Model Vendors
On December 9, 2025, the Third-Party Data and Models (H) Working Group, which reports to the Innovation Cybersecurity and Technology (H)…